MedTrace Logo

A Prospective Multicenter Study To Assess The Clinical Outcomes Of Current Phacoemulsification Approach To Cataract Extraction Versus The Micor System Device

NCT05729477 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 402

Last updated 2026-05-14

Study results available
· View outcomes & findings →

Summary

The purpose of this research study is to evaluate the clinical outcomes of current phacoemulsification approaches to cataract extraction involving high-frequency thermogenic energy versus the use of the MICOR System device using low-energy segment removal with a micro-interventional irrigation/aspiration port to evacuate the lens in subjects undergoing routine cataract surgery.

Conditions

  • Cataract Surgery

Interventions

DEVICE

miCOR System

The miCOR system is a lens fragmentation device used to break up the cataract prior to IOL implantation during cataract surgery.

DEVICE

Phaco Subject Cohort

Phaco Subject Cohort

Sponsors & Collaborators

  • Carl Zeiss Meditec, Inc.

    lead INDUSTRY

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SEQUENTIAL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-12-06
Primary Completion
2025-11-30
Completion
2025-12-30
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05729477 on ClinicalTrials.gov